BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37188987)

  • 1. Magnetic resonance imaging for treatment response evaluation and prognostication of hepatocellular carcinoma after thermal ablation.
    Zhang Y; Wei H; Song B
    Insights Imaging; 2023 May; 14(1):87. PubMed ID: 37188987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation: A Comprehensive Review.
    Habibollahi P; Sheth RA; Cressman ENK
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma.
    Luerken L; Haimerl M; Doppler M; Uller W; Beyer LP; Stroszczynski C; Einspieler I
    Rofo; 2022 Oct; 194(10):1075-1086. PubMed ID: 35545102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
    Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
    Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma.
    Ricke J; Steffen IG; Bargellini I; Berg T; Bilbao Jaureguizar JI; Gebauer B; Iezzi R; Loewe C; Karçaaltincaba M; Pech M; Sengel C; van Delden O; Vandecaveye V; Zech CJ; Seidensticker M
    JHEP Rep; 2020 Dec; 2(6):100173. PubMed ID: 33103093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics nomogram based on multi-parametric magnetic resonance imaging for predicting early recurrence in small hepatocellular carcinoma after radiofrequency ablation.
    Zhang X; Wang C; Zheng D; Liao Y; Wang X; Huang Z; Zhong Q
    Front Oncol; 2022; 12():1013770. PubMed ID: 36439458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma.
    Yoo SH; Choi JY; Jang JW; Bae SH; Yoon SK; Kim DG; Yoo YK; Rha SE; Lee YJ; Jung ES
    Ann Surg Oncol; 2013 Sep; 20(9):2893-900. PubMed ID: 23649931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.
    Minami Y; Nishida N; Kudo M
    World J Gastroenterol; 2014 Apr; 20(15):4160-6. PubMed ID: 24764654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients.
    Granata V; Grassi R; Fusco R; Setola SV; Belli A; Piccirillo M; Pradella S; Giordano M; Cappabianca S; Brunese L; Grassi R; Petrillo A; Izzo F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Wang F; Numata K; Nihonmatsu H; Chuma M; Moriya S; Nozaki A; Ogushi K; Fukuda H; Ruan L; Okada M; Luo W; Koizumi N; Nakano M; Otani M; Inayama Y; Maeda S
    Int J Hyperthermia; 2020; 37(1):1149-1158. PubMed ID: 32996799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response.
    Abdelrahman AS; Ekladious MEY; Badran EM; Madkour SS
    Diagn Interv Imaging; 2022 Nov; 103(11):524-534. PubMed ID: 35787988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation.
    Lv X; Chen M; Kong C; Shu G; Meng M; Ye W; Cheng S; Zheng L; Fang S; Chen C; Wu F; Weng Q; Tu J; Zhao Z; Ji J
    Eur J Radiol; 2021 Nov; 144():109955. PubMed ID: 34600237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
    Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR Imaging Biomarkers for the Prediction of Outcome after Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessments of the Liver Imaging Reporting and Data System and Radiomic Features.
    Petukhova-Greenstein A; Zeevi T; Yang J; Chai N; DiDomenico P; Deng Y; Ciarleglio M; Haider SP; Onyiuke I; Malpani R; Lin M; Kucukkaya AS; Gottwald LA; Gebauer B; Revzin M; Onofrey J; Staib L; Gunabushanam G; Taddei T; Chapiro J
    J Vasc Interv Radiol; 2022 Jul; 33(7):814-824.e3. PubMed ID: 35460887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma.
    Minami Y; Aoki T; Hagiwara S; Kudo M
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.